Laurel Habel to Estrogen Replacement Therapy
This is a "connection" page, showing publications Laurel Habel has written about Estrogen Replacement Therapy.
Connection Strength
0.268
-
Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008 Apr 16; 100(8):597-8; author reply 599.
Score: 0.075
-
Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst. 2008 Apr 16; 100(8):563-71.
Score: 0.075
-
Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women. Menopause. 2007 May-Jun; 14(3 Pt 1):391-6.
Score: 0.070
-
Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA. 1995 Jul 12; 274(2):137-42.
Score: 0.031
-
The association between mammographic breast density and bone mineral density in the study of women's health across the nation. Ann Epidemiol. 2007 Aug; 17(8):575-83.
Score: 0.018